BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 32432818)

  • 21. Heterogeneous brain FDG-PET metabolic patterns in patients with C9orf72 mutation.
    Castelnovo V; Caminiti SP; Riva N; Magnani G; Silani V; Perani D
    Neurol Sci; 2019 Mar; 40(3):515-521. PubMed ID: 30554355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of spinal cord atrophy using phase sensitive inversion recovery (PSIR) imaging in motor neuron disease.
    Olney NT; Bischof A; Rosen H; Caverzasi E; Stern WA; Lomen-Hoerth C; Miller BL; Henry RG; Papinutto N
    PLoS One; 2018; 13(11):e0208255. PubMed ID: 30496320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of the caudate nucleus head and its networks in sporadic amyotrophic lateral sclerosis-frontotemporal dementia continuum.
    Masuda M; Senda J; Watanabe H; Epifanio B; Tanaka Y; Imai K; Riku Y; Li Y; Nakamura R; Ito M; Ishigaki S; Atsuta N; Koike H; Katsuno M; Hattori N; Naganawa S; Sobue G
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(7-8):571-579. PubMed ID: 27684890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain ¹⁸F-FDG and ¹¹C-PiB PET findings in two siblings with FTD/ALS associated with the C9ORF72 repeat expansion.
    Martikainen MH; Gardberg M; Jansson L; Röyttä M; Rinne JO; Kaasinen V
    Neurocase; 2014 Apr; 20(2):150-7. PubMed ID: 23216213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional prefrontal cortical atrophy predicts specific cognitive-behavioral symptoms in ALS-FTD.
    Ratti E; Domoto-Reilly K; Caso C; Murphy A; Brickhouse M; Hochberg D; Makris N; Cudkowicz ME; Dickerson BC
    Brain Imaging Behav; 2021 Oct; 15(5):2540-2551. PubMed ID: 33587281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic resonance imaging and magnetic resonance spectroscopy in a patient with amyotrophic lateral sclerosis and frontotemporal dementia.
    Sarac H; Zagar M; Vranjes D; Henigsberg N; Bilić E; Pavlisa G
    Coll Antropol; 2008 Jan; 32 Suppl 1():205-10. PubMed ID: 18405084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multimodal MRI quantification of the common neurostructural bases within the FTD-ALS continuum.
    Crespi C; Dodich A; Cappa SF; Canessa N; Iannaccone S; Corbo M; Lunetta C; Falini A; Cerami C
    Neurobiol Aging; 2018 Feb; 62():95-104. PubMed ID: 29131982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis.
    Pagani M; Chiò A; Valentini MC; Öberg J; Nobili F; Calvo A; Moglia C; Bertuzzo D; Morbelli S; De Carli F; Fania P; Cistaro A
    Neurology; 2014 Sep; 83(12):1067-74. PubMed ID: 25122207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 18F-FDG-PET correlates of cognitive impairment in ALS.
    Canosa A; Pagani M; Cistaro A; Montuschi A; Iazzolino B; Fania P; Cammarosano S; Ilardi A; Moglia C; Calvo A; Chiò A
    Neurology; 2016 Jan; 86(1):44-9. PubMed ID: 26590270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tackling clinical heterogeneity across the amyotrophic lateral sclerosis-frontotemporal dementia spectrum using a transdiagnostic approach.
    Ahmed RM; Bocchetta M; Todd EG; Tse NY; Devenney EM; Tu S; Caga J; Hodges JR; Halliday GM; Irish M; Kiernan MC; Piguet O; Rohrer JD
    Brain Commun; 2021; 3(4):fcab257. PubMed ID: 34805999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Graph network measures reveal distinct white matter abnormalities in motor and extra-motor brain regions of two UMN-predominant ALS subtypes.
    Rajagopalan V; Pioro EP
    J Neurol Sci; 2023 Sep; 452():120765. PubMed ID: 37672915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered speech-related cortical network in frontotemporal dementia.
    Suppa A; Fabbrini A; Guerra A; Petsas N; Asci F; Di Stasio F; Trebbastoni A; Vasselli F; De Lena C; Pantano P; Berardelli A
    Brain Stimul; 2020; 13(3):765-773. PubMed ID: 32289706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 18F-florbetapir PET in patients with frontotemporal dementia and Alzheimer disease.
    Kobylecki C; Langheinrich T; Hinz R; Vardy ER; Brown G; Martino ME; Haense C; Richardson AM; Gerhard A; Anton-Rodriguez JM; Snowden JS; Neary D; Pontecorvo MJ; Herholz K
    J Nucl Med; 2015 Mar; 56(3):386-91. PubMed ID: 25655625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CSF sAPPβ, YKL-40, and NfL along the ALS-FTD spectrum.
    Illán-Gala I; Alcolea D; Montal V; Dols-Icardo O; Muñoz L; de Luna N; Turón-Sans J; Cortés-Vicente E; Sánchez-Saudinós MB; Subirana A; Sala I; Blesa R; Clarimón J; Fortea J; Rojas-García R; Lleó A
    Neurology; 2018 Oct; 91(17):e1619-e1628. PubMed ID: 30291183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in gray and white matter
    Son HJ; Oh JS; Roh JH; Seo SW; Oh M; Lee SJ; Oh SJ; Kim JS
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):357-366. PubMed ID: 30109402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interhemispheric connectivity in amyotrophic lateral sclerosis: A near-infrared spectroscopy and diffusion tensor imaging study.
    Kopitzki K; Oldag A; Sweeney-Reed CM; Machts J; Veit M; Kaufmann J; Hinrichs H; Heinze HJ; Kollewe K; Petri S; Mohammadi B; Dengler R; Kupsch AR; Vielhaber S
    Neuroimage Clin; 2016; 12():666-672. PubMed ID: 27761397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cortical markers of cognitive syndromes in amyotrophic lateral sclerosis.
    Consonni M; Contarino VE; Catricalà E; Dalla Bella E; Pensato V; Gellera C; Lauria G; Cappa SF
    Neuroimage Clin; 2018; 19():675-682. PubMed ID: 30023173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brainstem pathology in amyotrophic lateral sclerosis and primary lateral sclerosis: A longitudinal neuroimaging study.
    Bede P; Chipika RH; Finegan E; Li Hi Shing S; Doherty MA; Hengeveld JC; Vajda A; Hutchinson S; Donaghy C; McLaughlin RL; Hardiman O
    Neuroimage Clin; 2019; 24():102054. PubMed ID: 31711033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disruption of the white matter structural network and its correlation with baseline progression rate in patients with sporadic amyotrophic lateral sclerosis.
    Li W; Wei Q; Hou Y; Lei D; Ai Y; Qin K; Yang J; Kemp GJ; Shang H; Gong Q
    Transl Neurodegener; 2021 Sep; 10(1):35. PubMed ID: 34511130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary lateral sclerosis and the amyotrophic lateral sclerosis-frontotemporal dementia spectrum.
    Agarwal S; Highton-Williamson E; Caga J; Matamala JM; Dharmadasa T; Howells J; Zoing MC; Shibuya K; Geevasinga N; Vucic S; Hodges JR; Ahmed RM; Kiernan MC
    J Neurol; 2018 Aug; 265(8):1819-1828. PubMed ID: 29868980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.